These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 14987745)

  • 21. Formiminotransferase cyclodeaminase is an organ-specific autoantigen recognized by sera of patients with autoimmune hepatitis.
    Lapierre P; Hajoui O; Homberg JC; Alvarez F
    Gastroenterology; 1999 Mar; 116(3):643-9. PubMed ID: 10029623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver/kidney microsomal antibody type 1 and liver cytosol antibody type 1 concentrations in type 2 autoimmune hepatitis.
    Muratori L; Cataleta M; Muratori P; Lenzi M; Bianchi FB
    Gut; 1998 May; 42(5):721-6. PubMed ID: 9659171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the antigenicity of the formiminotransferase-cyclodeaminase in type 2 autoimmune hepatitis.
    Renous R; Lapierre P; Djilali-Saiah I; Vitozzi S; Alvarez F
    Exp Cell Res; 2004 Jan; 292(2):332-41. PubMed ID: 14697341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-soluble liver antigen (SLA) antibodies in chronic HCV infection.
    Vitozzi S; Lapierre P; Djilali-Saiah I; Marceau G; Beland K; Alvarez F
    Autoimmunity; 2004 May; 37(3):217-22. PubMed ID: 15497455
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autoantibody Profiling in a Cohort of Pediatric and Adult Patients With Autoimmune Hepatitis.
    Villalta D; Girolami E; Alessio MG; Sorrentino MC; Tampoia M; Brusca I; Daves M; Porcelli B; Barberio G; Conte M; Pantarotto L; Bizzaro N;
    J Clin Lab Anal; 2016 Jan; 30(1):41-6. PubMed ID: 25242745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and analysis of cytochrome P450IID6 antigenic sites recognized by anti-liver-kidney microsome type-1 antibodies (LKM1).
    Yamamoto AM; Cresteil D; Boniface O; Clerc FF; Alvarez F
    Eur J Immunol; 1993 May; 23(5):1105-11. PubMed ID: 7682958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunological cross-reactivity to multiple autoantigens in patients with liver kidney microsomal type 1 autoimmune hepatitis.
    Choudhuri K; Gregorio GV; Mieli-Vergani G; Vergani D
    Hepatology; 1998 Nov; 28(5):1177-81. PubMed ID: 9794898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autoimmune hepatitis: evolving concepts.
    Diamantis I; Boumpas DT
    Autoimmun Rev; 2004 Mar; 3(3):207-14. PubMed ID: 15110233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical features and effect of antiviral therapy on anti-liver/kidney microsomal antibody type 1 positive chronic hepatitis C.
    Ferri S; Muratori L; Quarneti C; Muratori P; Menichella R; Pappas G; Granito A; Ballardini G; Bianchi FB; Lenzi M
    J Hepatol; 2009 Jun; 50(6):1093-101. PubMed ID: 19398235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver cytosolic 1 antigen-antibody system in type 2 autoimmune hepatitis and hepatitis C virus infection.
    Lenzi M; Manotti P; Muratori L; Cataleta M; Ballardini G; Cassani F; Bianchi FB
    Gut; 1995 May; 36(5):749-54. PubMed ID: 7797126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a new autoantibody in patients with chronic hepatitis.
    Fukuda Y; Yotsuyanagi H; Ooka S; Sekine T; Koike J; Takano T; Suzuki M; Itoh F; Nishioka K; Kato T
    Hum Immunol; 2004 Dec; 65(12):1530-8. PubMed ID: 15603881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differences in antigenic sites, recognized by anti-liver-kidney microsome-1 (LKM-1) autoantibody, between HCV-positive and HCV-negative sera in Japanese patients.
    Miyakawa H; Matsushima H; Narita Y; Hankins RW; Kitazawa E; Fujikawa H; Kikuchi K; Matsushita M; Abe K; Kawaguchi N; Morizane T; Kako M
    J Gastroenterol; 1998 Aug; 33(4):529-35. PubMed ID: 9719237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Heterogeneity of antimicrosomal autoantibodies in chronic hepatitis C virus infection and delta hepatitis].
    Durazzo M; Costa C; Schmidt E; Loges S; Scaglione L; Touscoz AG; Smedile A; Manns MP; Rizzetto M; Pagano G
    Ann Ital Med Int; 1995; 10(2):93-7. PubMed ID: 7542466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of anti-LKM-1(anti-CYP2D6) by an enzyme-linked immunosorbent assay in adult patients with chronic liver diseases.
    Miyakawa H; Kikazawa E; Abe K; Kikuchi K; Fujikawa H; Matsushita M; Kawaguchi N; Morizane T; Ohya K; Kako M
    Autoimmunity; 1999; 30(2):107-14. PubMed ID: 10435724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Autoimmune hepatitis in a girl with presence of anti-LKM1 antibodies].
    Larraín F; Miquel JF; González S
    Rev Med Chil; 1997 Jun; 125(6):683-9. PubMed ID: 9515288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-neutrophil cytoplasmic antibodies in type 1 and 2 autoimmune hepatitis.
    Zauli D; Ghetti S; Grassi A; Descovich C; Cassani F; Ballardini G; Muratori L; Bianchi FB
    Hepatology; 1997 May; 25(5):1105-7. PubMed ID: 9141425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoantibodies in autoimmune hepatitis: anti-liver kidney microsome type 1 (anti-LKM1) and anti-liver cytosol type 1 (anti-LC1) antibodies.
    Johanet C; Ballot E
    Clin Res Hepatol Gastroenterol; 2013 Apr; 37(2):216-8. PubMed ID: 23523312
    [No Abstract]   [Full Text] [Related]  

  • 38. Autoimmune hepatitis-specific antibodies against soluble liver antigen and liver cytosol type 1 in patients with chronic viral hepatitis.
    Rigopoulou EI; Mytilinaiou M; Romanidou O; Liaskos C; Dalekos GN
    J Autoimmune Dis; 2007 Feb; 4():2. PubMed ID: 17274827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic accuracy of atypical p-ANCA in autoimmune hepatitis using ROC- and multivariate regression analysis.
    Terjung B; Bogsch F; Klein R; Söhne J; Reichel C; Wasmuth JC; Beuers U; Sauerbruch T; Spengler U
    Eur J Med Res; 2004 Sep; 9(9):439-48. PubMed ID: 15546809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple viral/self immunological cross-reactivity in liver kidney microsomal antibody positive hepatitis C virus infected patients is associated with the possession of HLA B51.
    Bogdanos DP; Lenzi M; Okamoto M; Rigopoulou EI; Muratori P; Ma Y; Muratori L; Tsantoulas D; Mieli- Vergani G; Bianchi FB; Vergani D
    Int J Immunopathol Pharmacol; 2004; 17(1):83-92. PubMed ID: 15000871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.